samedan logo

 
 
spacer
home > pmps > summer 2017 > nemera – delivering effective devices
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Nemera – Delivering Effective Devices

Nemera always puts patients first, providing the most comprehensive range of devices in the sector, including off-the-shelf innovative systems, customised design development and contract manufacturing. Nemera's services and products cover several key delivery routes:

Ophthalmic

Nemera offers a multidose closing tip system, Novelia®, which avoids the need for preservatives in the drug and prevents bacterial contamination over the duration of treatment.

Novelia® is an innovative, userfriendly, preservative-free multidose eye dropper with a precision blue tip, commercialised for both medical devices and prescription drugs.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.


spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Vetter continues its successful performance at the 2021 CMO Leadership Awards

Ravensburg, Germany, February 18, 2021 – Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), was granted the 2021 CMO Leadership Awards in five core categories – quality, expertise, compatibility, capabilities, and service. The award, now in its tenth year, was given by the leading trade press publication, Life Science Leader. Vetter was also the recipient of the award in a variety of categories in previous years.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement